517 related articles for article (PubMed ID: 10728704)
1. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
Eberhard A; Kahlert S; Goede V; Hemmerlein B; Plate KH; Augustin HG
Cancer Res; 2000 Mar; 60(5):1388-93. PubMed ID: 10728704
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors.
Kalinski T; Sel S; Kouznetsova I; Röpke M; Roessner A
Pathol Res Pract; 2009; 205(5):339-45. PubMed ID: 19157720
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in wound healing and tumor metastasis.
Ruiter DJ; Schlingemann RO; Westphal JR; Denijn M; Rietveld FJ; De Waal RM
Behring Inst Mitt; 1993 Aug; (92):258-72. PubMed ID: 7504453
[TBL] [Abstract][Full Text] [Related]
4. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
Shrivastav S; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
[TBL] [Abstract][Full Text] [Related]
5. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation.
Vartanian RK; Weidner N
Lab Invest; 1995 Dec; 73(6):844-50. PubMed ID: 8558846
[TBL] [Abstract][Full Text] [Related]
7. Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients.
Yonenaga Y; Mori A; Onodera H; Yasuda S; Oe H; Fujimoto A; Tachibana T; Imamura M
Oncology; 2005; 69(2):159-66. PubMed ID: 16127287
[TBL] [Abstract][Full Text] [Related]
8. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma.
Lu C; Kamat AA; Lin YG; Merritt WM; Landen CN; Kim TJ; Spannuth W; Arumugam T; Han LY; Jennings NB; Logsdon C; Jaffe RB; Coleman RL; Sood AK
Clin Cancer Res; 2007 Jul; 13(14):4209-17. PubMed ID: 17634550
[TBL] [Abstract][Full Text] [Related]
9. Chemo-angiogenic profile of bovine urinary bladder tumors distinguishes urothelial carcinomas from hemangiosarcomas.
Carvalho T; Elias AP; Nunes T; Peleteiro MC; Dias S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):344-58. PubMed ID: 18022698
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue.
Schlingemann RO; Rietveld FJ; Kwaspen F; van de Kerkhof PC; de Waal RM; Ruiter DJ
Am J Pathol; 1991 Jun; 138(6):1335-47. PubMed ID: 1711288
[TBL] [Abstract][Full Text] [Related]
11. Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density.
Emoto M; Iwasaki H; Mimura K; Kawarabayashi T; Kikuchi M
Cancer; 1997 Sep; 80(5):899-907. PubMed ID: 9307190
[TBL] [Abstract][Full Text] [Related]
12. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
Raza A; Franklin MJ; Dudek AZ
Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
[TBL] [Abstract][Full Text] [Related]
13. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
[TBL] [Abstract][Full Text] [Related]
14. The enigmatic role of angiopoietin-1 in tumor angiogenesis.
Metheny-Barlow LJ; Li LY
Cell Res; 2003 Oct; 13(5):309-17. PubMed ID: 14672554
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis in malignant tumors.
Sarcević B
Acta Med Croatica; 2001; 55(4-5):187-90. PubMed ID: 12398022
[TBL] [Abstract][Full Text] [Related]
17. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
18. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
[TBL] [Abstract][Full Text] [Related]
19. Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression.
Augustin HG; Braun K; Telemenakis I; Modlich U; Kuhn W
Am J Pathol; 1995 Aug; 147(2):339-51. PubMed ID: 7543733
[TBL] [Abstract][Full Text] [Related]
20. Pericytes from human non-small cell lung carcinomas: an attractive target for anti-angiogenic therapy.
Bagley RG; Rouleau C; Morgenbesser SD; Weber W; Cook BP; Shankara S; Madden SL; Teicher BA
Microvasc Res; 2006 May; 71(3):163-74. PubMed ID: 16624341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
